Nigeria’s Reliance on Imported Drug Ingredients Threatens Medicine Security

Stakeholders have expressed concerns about Nigeria’s heavy reliance on imported drug ingredients, according to a report by Premium Times Nigeria. The concern is that this reliance poses a significant threat to the country’s medicine security.

Although Nigeria has pharmaceutical companies that manufacture finished medicines, many of these companies depend on imported Active Pharmaceutical Ingredients (APIs) and other raw materials to produce the medicines.

The potential danger lies in the fact that these imported ingredients may not always meet the required standards, or they may be subject to sudden price increases or supply disruptions.

The Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) has called on the government to prioritize the local production of APIs to reduce the country’s reliance on imported ingredients.

The group has also urged the government to provide incentives for local API producers, such as tax breaks and subsidies, to encourage their growth and competitiveness.

The issue of medicine security is particularly important in Nigeria, given the country’s high burden of disease and the need for affordable and accessible medicines.

The National Agency for Food and Drug Administration and Control (NAFDAC) has not yet commented on the concerns raised by the stakeholders.